Biography and Research Information
OverviewAI-generated summary
Rishi Kumar Jaiswal's research focuses on molecular mechanisms underlying cancer development and potential therapeutic strategies. His work has investigated the role of PARP-1 in non-small cell lung carcinoma, specifically its induction of epithelial-mesenchymal transition (EMT) through modulation of transcription factors. Jaiswal has also explored the function of mammalian STN1, finding that its deficiency promotes colon cancer development by inhibiting DNA repair. Further research by Jaiswal examines the protective mechanisms of STN1 against replication stress and aberrant DNA resection, involving CaMKK2 and CHK1 phosphorylation. Additionally, his publications address broader health topics, including the application of nanotechnology in combating SARS-CoV-2, the efficacy of immunotherapies against cancer, and the assessment of COVID-19 vaccination strategies.
Metrics
- h-index: 11
- Publications: 41
- Citations: 493
Selected Publications
-
Circulating miRNA in metabolic syndrome and cancer: Machinery, diagnostics, and therapeutics (2026)
-
Navigating the Biological Landscape: Barriers to Effective Theranostic Development and Delivery (2026)
-
Editorial: The role of nod-like receptor (NLR) family of proteins in inflammation (2026)
Collaboration Network
Top Collaborators
- Editorial: The role of nod-like receptor (NLR) family of proteins in inflammation
- Editorial: The role of nod-like receptor (NLR) family of proteins in inflammation
- Editorial: The role of nod-like receptor (NLR) family of proteins in inflammation
Similar Researchers
Based on overlapping research topics